stella
beta
iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009 — Stella
Recruiting
Back to Huntington Disease trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
Belgium
Universitaire Ziekenhuizen Leuven/ UZ Leuven/ UZL, Leuven
View full record on ClinicalTrials.gov